Pharma Surge

Pharma Surge

🇺🇸·10h agoIndustry

Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT) today announced that...

Publisher

I
Immunovant

USA

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Immunovant
Region
USA
Scope
Industry
Published
July 24, 2026
Language
EN

Topics

autoimmunebiotech

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Summary excerpt

DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT) today announced that...

Source route

Continue on immunovant.com

Leave the platform to read the original full article on the publisher site.

Source: Immunovant

Scope: Industry

Open original article
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026 | Pharma Surge